Mechtild Harf Research Program

For the study of hematopoietic stem cell transplantation and cell therapies of hematologic malignancies

This Program, dedicated to the memory of Mechtild Harf, is intended to provide research grants to promising developing investigators to advance the understanding of complications and therapeutic strategies in the context of hematopoietic cell transplantation and/or cellular therapies for hematologic malignancies. The program is funded and administered by DKMS.

Applications can be submitted from October 1st - January 31st.

Description of the Grant

DKMS

The Mechtild Harf Research Program provides two awards annually with a preference for one application focused on clinical research and one focused on laboratory based research. Grants consist of a maximum of €240,000 support over three years, contingent on adequate progress of the research. Each funding year runs from July 1st to June 30th. Two scholars will be selected from among the eligible applications for the funding period July 1st.

MH-2 300

The research proposal must address issues of hematopoietic transplantation and/or cell therapies for hematologic malignancies. These studies can range from cellular to pre-clinical animal models to human studies including co-funded clinical trials.

Qualifications of the Principal Investigator

Applicants must have received a doctoral degree (M.D., Ph.D., or equivalent) in a field pertinent to the award within the past twelve years. Applicants do not have to hold a faculty position and can be in training (Fellows, Postdoctoral Fellows and Junior Faculty). Applicants from all countries are invited to submit an application.

DKMS
DKMS
DKMS

Applications can be submitted from October 1st - January 31st

Please download these documents to apply:

1) Application Instructions MHRG

2) MHRG Cover Sheet

3) Budget Template

4) Declaration of Agreement

5) MHRG Funding Guidelines